Open access · CC-BY
via OpenAlex
Inhibition of IL-11 signalling extends mammalian healthspan and lifespan
Anissa Anindya Widjaja, Wei‐Wen Lim, Sivakumar Viswanathan, Sonia Pankaj Chothani, Ben Corden, Dasan Mary Cibi, Joyce Wei Ting Goh, Radiance Lim, Brijesh Kumar Singh, Jessie Tan, Chee Jian Pua, Sze Yun Lim, Eleonora Adami, Sebastian Schäfer, Benjamin L. George
Nature · 2024 · ▲ 258 citations
Abstract
Abstract For healthspan(definition) and lifespan, ERK, AMPK and mTORC1 represent critical pathways and inflammation is a centrally important hallmark 1–7 . Here we examined whether IL-11, a pro-inflammatory cytokine of the IL-6 family, has a negative effect on age-associated disease and lifespan. As mice age, IL-11 is upregulated across cell types and tissues to regulate an ERK–AMPK–mTORC1 axis to modulate cellular, tissue- and organismal-level ageing pathologies. Deletion of Il11 or Il11ra1 protects against metabolic decline, multi-morbidity and frailty in old age. Administration of anti-IL-11 to 75-week-old mice for 25 weeks improves metabolism and muscle function, and reduces ageing biomarkers and frailty across sexes. In lifespan studies, genetic deletion of Il11 extended the lives of mice of both sexes, by 24.9% on average. Treatment with anti-IL-11 from 75 weeks of age until death extends the median lifespan of male mice by 22.5% and of female mice by 25%. Together, these results demonstrate a role for the pro-inflammatory factor IL-11 in mammalian healthspan and lifespan. We suggest that anti-IL-11 therapy, which is currently in early-stage clinical trials for fibrotic lung disease, may provide a translational opportunity to determine the effects of IL-11 inhibition on ageing pathologies in older people.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41586-024-07701-9
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Widjaja, A.A., Lim, W., Viswanathan, S., Chothani, S.P., Corden, B., Cibi, D.M., Goh, J.W.T., Lim, R., Singh, B.K., Tan, J., Pua, C.J., Lim, S.Y., Adami, E., Schäfer, S., George, B.L., Sweeney, M., Xie, C., Tripathi, M., Sims, N.A., & Hübner, N. (2024). Inhibition of IL-11 signalling extends mammalian healthspan and lifespan. <em>Nature</em>. https://doi.org/10.1038/s41586-024-07701-9
Vancouver
Widjaja AA, Lim W, Viswanathan S, Chothani SP, Corden B, Cibi DM, et al. Inhibition of IL-11 signalling extends mammalian healthspan and lifespan. Nature. 2024. doi:10.1038/s41586-024-07701-9.
BibTeX
@article{anissa2024Inhibi,
title = {Inhibition of IL-11 signalling extends mammalian healthspan and lifespan},
author = {Anissa Anindya Widjaja and Wei‐Wen Lim and Sivakumar Viswanathan and Sonia Pankaj Chothani and Ben Corden and Dasan Mary Cibi and Joyce Wei Ting Goh and Radiance Lim and Brijesh Kumar Singh and Jessie Tan and Chee Jian Pua and Sze Yun Lim and Eleonora Adami and Sebastian Schäfer and Benjamin L. George and Mark Sweeney and Chen Xie and Madhulika Tripathi and Natalie A. Sims and Norbert Hübner and Enrico G. Petretto and Dominic J. Withers and Lena Ho and Jesús Gil and David Carling},
journal = {Nature},
year = {2024},
doi = {10.1038/s41586-024-07701-9},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
bioRxiv (Cold Spring Harbor Laboratory) 2023
Preprint · CC-BY
Inhibition of an immunometabolic axis of mTORC1 activation extends mammalian healthspan
Nucleic Acids Research 1997
Open access · OA
Multi-Organ Characterization of Mitochondrial Genomic Rearrangements in Ad Libitum and Caloric Restricted Mice Show Striking Somatic Mitochondrial DNA Rearrangements with Age
PubMed Central 2026
Preprint · CC-BY
Lifelong restriction of dietary valine has sex-specific benefits for health and lifespan in mice
Nature 2012
Citation only
The sirtuin SIRT6 regulates lifespan in male mice
Aging 2022
Open access · CC-BY
Long-term treatment with chloroquine increases lifespan in middle-aged male mice possibly via autophagy modulation, proteasome inhibition and glycogen metabolism
Pharmacology & Therapeutics 2012
Citation only